布地奈德对单核细胞与结肠癌细胞免疫交叉对话的调节作用

D. Meir, B. Hanna
{"title":"布地奈德对单核细胞与结肠癌细胞免疫交叉对话的调节作用","authors":"D. Meir, B. Hanna","doi":"10.23937/2378-3672/1410029","DOIUrl":null,"url":null,"abstract":"Background: The introduction of corticosteroids in the therapeutic armamentarium has been a great contribution to human health. Budesonide, a semi-synthetic glucocorticoid derivative gained its popularity due to its anti-inflammatory, immunosuppressive and even anti-carcinogenic properties. In this study we examine the effect of budesonide on the immune dialogue between peripheral blood mononuclear cells and colon carcinoma cells from two human lines. Methods: Unstimulated peripheral blood mononuclear cells or cells stimulated with either lipopolysaccharide or phorbol myristate acetate/ionomycin were incubated without or with budesonide at 10-8 M, 10-7 M and 10-6 M and the production of TNFα, IL-1β, IL-6, IFNγ, IL-2, IL-1ra and IL-10 was examined applying ELISA method. In another set of experiments peripheral blood mononuclear cells were co-cultured with HT-29 or RKO colon carcinoma cells in the absence or presence of budesonide and the secretion of the abovementioned cytokines was evaluated. Results: Budesonide caused reduced proliferation of peripheral blood mononuclear cells, HT-29 or RKO at 10-8 M as tested by XTT test, but had no effect at higher concentrations. The secretion of TNFα, IL-1β and IL-6 by non-stimulated peripheral blood mononuclear cells or cells stimulated with either lipopolysaccharide or cells from both colon cancer lines was inhibited upon incubation with budesonide at concentrations between 10-8 M and 10-6 M. The production of IL-2 by phorbol myristate acetate/ionomycin treated peripheral blood mononuclear cells or cells stimulated with HT-29 colon cancer cells was suppressed by budesonide, but IL-2 secretion by RKO stimulated peripheral blood mononuclear cells was not affected. Budesonide did not influence the secretion of IFNγ by non-stimulated peripheral blood mononuclear cells or by cells stimulated with PMA/ionomycin. However, HT-29 and RKO-induced production of IFNγ was inhibited by the three budesonide concentrations. Budesonide caused reduced secretion of IL-10 by non-stimulated peripheral blood mononuclear cells, or by cells stimulated with either lipopolysaccharide or RKO cancer cells, whereas that induced by HT-29 cells was not affected. IL1ra synthesis by non-stimulated peripheral blood mononuclear cells or cell stimulated with HT-29 colon cancer cells was inhibited upon 24 hrs incubation with budesonide, while that produced by lipopolysaccharide or RKO stimulated PBMC was not affected. Conclusions: It appears that the capacity of budesonide to modify the immune dialogue between mononuclear and certain types of cancer cells may be one of the ways by which this glucocorticosteroid may affect tumorigenesis.","PeriodicalId":92912,"journal":{"name":"International journal of immunology and immunotherapy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Budesonide Modulates the Immune Cross-Talk between Mononuclear and Colon Cancer Cells\",\"authors\":\"D. Meir, B. Hanna\",\"doi\":\"10.23937/2378-3672/1410029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The introduction of corticosteroids in the therapeutic armamentarium has been a great contribution to human health. Budesonide, a semi-synthetic glucocorticoid derivative gained its popularity due to its anti-inflammatory, immunosuppressive and even anti-carcinogenic properties. In this study we examine the effect of budesonide on the immune dialogue between peripheral blood mononuclear cells and colon carcinoma cells from two human lines. Methods: Unstimulated peripheral blood mononuclear cells or cells stimulated with either lipopolysaccharide or phorbol myristate acetate/ionomycin were incubated without or with budesonide at 10-8 M, 10-7 M and 10-6 M and the production of TNFα, IL-1β, IL-6, IFNγ, IL-2, IL-1ra and IL-10 was examined applying ELISA method. In another set of experiments peripheral blood mononuclear cells were co-cultured with HT-29 or RKO colon carcinoma cells in the absence or presence of budesonide and the secretion of the abovementioned cytokines was evaluated. Results: Budesonide caused reduced proliferation of peripheral blood mononuclear cells, HT-29 or RKO at 10-8 M as tested by XTT test, but had no effect at higher concentrations. The secretion of TNFα, IL-1β and IL-6 by non-stimulated peripheral blood mononuclear cells or cells stimulated with either lipopolysaccharide or cells from both colon cancer lines was inhibited upon incubation with budesonide at concentrations between 10-8 M and 10-6 M. The production of IL-2 by phorbol myristate acetate/ionomycin treated peripheral blood mononuclear cells or cells stimulated with HT-29 colon cancer cells was suppressed by budesonide, but IL-2 secretion by RKO stimulated peripheral blood mononuclear cells was not affected. Budesonide did not influence the secretion of IFNγ by non-stimulated peripheral blood mononuclear cells or by cells stimulated with PMA/ionomycin. However, HT-29 and RKO-induced production of IFNγ was inhibited by the three budesonide concentrations. Budesonide caused reduced secretion of IL-10 by non-stimulated peripheral blood mononuclear cells, or by cells stimulated with either lipopolysaccharide or RKO cancer cells, whereas that induced by HT-29 cells was not affected. IL1ra synthesis by non-stimulated peripheral blood mononuclear cells or cell stimulated with HT-29 colon cancer cells was inhibited upon 24 hrs incubation with budesonide, while that produced by lipopolysaccharide or RKO stimulated PBMC was not affected. Conclusions: It appears that the capacity of budesonide to modify the immune dialogue between mononuclear and certain types of cancer cells may be one of the ways by which this glucocorticosteroid may affect tumorigenesis.\",\"PeriodicalId\":92912,\"journal\":{\"name\":\"International journal of immunology and immunotherapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of immunology and immunotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2378-3672/1410029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of immunology and immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2378-3672/1410029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:皮质类固醇在治疗设备中的引入对人类健康做出了巨大贡献。布地奈德是一种半合成的糖皮质激素衍生物,因其抗炎、免疫抑制甚至抗癌特性而广受欢迎。在这项研究中,我们检测了布地奈德对来自两个人类系的外周血单核细胞和结肠癌细胞之间的免疫对话的影响。方法:将未刺激的外周血单个核细胞或脂多糖或佛波酯-肉豆蔻酸酯/离子霉素刺激的细胞在10-8M、10-7M和10-6M条件下与布地奈德一起孵育,并用ELISA法检测TNFα、IL-1β、IL-6、IFNγ、IL-2、IL-1ra和IL-10的产生。在另一组实验中,在不存在或存在布地奈德的情况下,将外周血单核细胞与HT-29或RKO结肠癌细胞共培养,并评估上述细胞因子的分泌。结果:布地奈德在10-8M时可降低外周血单核细胞、HT-29或RKO的增殖,但在较高浓度时没有影响。非刺激性外周血单核细胞或用脂多糖或两种癌症系细胞刺激的细胞分泌TNFα、IL-1β和IL-6在与浓度为10-8M至10-6M的布地奈德孵育后受到抑制。佛波醇肉豆蔻酸盐/离子霉素处理的外周血单核细胞或HT-29结肠癌癌症细胞刺激的细胞产生IL-2受到布地奈德的抑制,但RKO刺激的外周血液单核细胞分泌IL-2不受影响。布地奈德不影响未刺激的外周血单核细胞或PMA/离子霉素刺激的细胞分泌IFNγ。然而,HT-29和RKO诱导的IFNγ的产生被三种浓度的布地奈德抑制。布地奈德导致非刺激的外周血单核细胞或用脂多糖或RKO癌症细胞刺激的细胞分泌IL-10减少,而HT-29细胞诱导的IL-10不受影响。非刺激性外周血单核细胞或HT-29结肠癌癌症细胞刺激的IL1ra合成在布地奈德孵育24小时后受到抑制,而脂多糖或RKO刺激的PBMC产生的IL1ra合成不受影响。结论:布地奈德改变单核细胞和某些类型癌症细胞之间免疫对话的能力可能是这种糖皮质激素影响肿瘤发生的途径之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Budesonide Modulates the Immune Cross-Talk between Mononuclear and Colon Cancer Cells
Background: The introduction of corticosteroids in the therapeutic armamentarium has been a great contribution to human health. Budesonide, a semi-synthetic glucocorticoid derivative gained its popularity due to its anti-inflammatory, immunosuppressive and even anti-carcinogenic properties. In this study we examine the effect of budesonide on the immune dialogue between peripheral blood mononuclear cells and colon carcinoma cells from two human lines. Methods: Unstimulated peripheral blood mononuclear cells or cells stimulated with either lipopolysaccharide or phorbol myristate acetate/ionomycin were incubated without or with budesonide at 10-8 M, 10-7 M and 10-6 M and the production of TNFα, IL-1β, IL-6, IFNγ, IL-2, IL-1ra and IL-10 was examined applying ELISA method. In another set of experiments peripheral blood mononuclear cells were co-cultured with HT-29 or RKO colon carcinoma cells in the absence or presence of budesonide and the secretion of the abovementioned cytokines was evaluated. Results: Budesonide caused reduced proliferation of peripheral blood mononuclear cells, HT-29 or RKO at 10-8 M as tested by XTT test, but had no effect at higher concentrations. The secretion of TNFα, IL-1β and IL-6 by non-stimulated peripheral blood mononuclear cells or cells stimulated with either lipopolysaccharide or cells from both colon cancer lines was inhibited upon incubation with budesonide at concentrations between 10-8 M and 10-6 M. The production of IL-2 by phorbol myristate acetate/ionomycin treated peripheral blood mononuclear cells or cells stimulated with HT-29 colon cancer cells was suppressed by budesonide, but IL-2 secretion by RKO stimulated peripheral blood mononuclear cells was not affected. Budesonide did not influence the secretion of IFNγ by non-stimulated peripheral blood mononuclear cells or by cells stimulated with PMA/ionomycin. However, HT-29 and RKO-induced production of IFNγ was inhibited by the three budesonide concentrations. Budesonide caused reduced secretion of IL-10 by non-stimulated peripheral blood mononuclear cells, or by cells stimulated with either lipopolysaccharide or RKO cancer cells, whereas that induced by HT-29 cells was not affected. IL1ra synthesis by non-stimulated peripheral blood mononuclear cells or cell stimulated with HT-29 colon cancer cells was inhibited upon 24 hrs incubation with budesonide, while that produced by lipopolysaccharide or RKO stimulated PBMC was not affected. Conclusions: It appears that the capacity of budesonide to modify the immune dialogue between mononuclear and certain types of cancer cells may be one of the ways by which this glucocorticosteroid may affect tumorigenesis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信